New Grant from the NIA

The Alder Research Group has received an R01 grant the National Institute of Aging (R01AG065879, “First-in-class Peptide Therapeutics for Mitochondrial Disorders: Molecular Mechanism of Action and Optimization of Design”). This is a five-year grant in the amount of $2.5M to support the development and analysis of therapeutic compounds for aging-related mitochondrial disorders.

New Site Launched

We are proud to announce the launch of our new website. Built on the the university Aurora service, this new version of our site sports a modern look, faster loading times, and works on all mobile and tablet devices.